Fondazione Policlinico Universitario Agostino Gemelli IRCCS: Carcinoma trials
The registry lists 11 Carcinoma studies with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 2 3No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.RecruitingNCT06640166Phase 2
- Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.RecruitingNCT06448936
- Hepatocellular Carcinoma Liver OrganoidsRecruitingNCT06355700Not applicable
- Multimodal Ultrasound and Hepatocellular Response to Local TreatmentsRecruitingNCT05987514Not applicable
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal MetastasesRecruitingNCT05371223Phase 2
- Nivolumab Plus Metformin in Metastatic Renal Cell CarcinomaTerminatedNCT06884683Phase 2
- Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?CompletedNCT06243965
- Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell CarcinomaStatus unknownNCT06041464
- European Multicenter Study on Surgical Management of Advanced Thyroid CancerStatus unknownNCT05796960
- European Multicentric Study on Parathyroid CarcinomaStatus unknownNCT05789680
- European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical CarcinomaStatus unknownNCT05763524